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We have i d e n t i f i e d f ive k ind reds w i t h fami l ia l 
medullary carcinoma of the thyroid (MTC) or mult iple 
endocrine neoplasia syndromes type 2 (MEN-2) in New 
Hampshire and Vermont dur ing the past five years. 
These families have been fo l lowed by periodic cal-
citonin testing after stimulation by calcium and pen-
tagastrin (1). Affected individuals have been treated by 
total thyroidectomy. 
Brattleboro Kindred 
Eight individuals with MTC and three with C-cell hyper-
plasia alone have undergone total thyroidectomy within 
the past five years at ages ranging f rom 19 to 72 years 
(Figure). Remarkably, no individual has as yet suffered 
any apparent ill eftect f rom the tumor even though 
regional lymph node metastases were present in two 
patients. 
The possibility of delayed or incomplete penetrance of 
the MTC gene is suggested by the f inding of positive 
stimulated calcitonin tests in two young men (IV-45 and 
IV-91); their mothers, the apparent obligate carriers of 
the MTC gene, have each had at least two normal stimu-
lated calcitonin tests at ages 41 and 39, respectively. 
These findings are unexpected since the MTC gene is 
believed to be fully penetrant at age 40 (2). Studies of 
katacalcin (3) and calcitonin gene-related peptide (4) 
secretion are currently underway to obtain further in-
formation about C-cell mass in these patients. 
To date, no evidence of pheochromocytoma has been 
found in this family. One 32-year-old man, who has not 
had a stimulated calci tonin test, had a parathyroid 
adenoma removed at age 18, but no other cases of 
hypercalcemia have been seen. 
New London Kindred 
Four individuals with MTC, aged 38 to 70, have had 
thyroidectomies in the past two years. A f i f th individual, 
now deceased, had metastatic MTC found by lymph 
node biopsy at age 67. An additional six individuals have 
had positive stimulated calcitonin tests. 
No pheochromocytomas or parathyroid disease have 
been recognized in this family to date. However, one 
individual wi th a positive stimulated calcitonin test has a 
marginal increase in urinary catecholamine metabolites 
and was hypercalcemic on one occasion. 
A 50-year-old member of the kindred was treated suc-
cessfully wi th radioiodine for Graves' disease 15 years 
ago and is scheduled for total thyroidectomy because of 
elevated calcitonin levels. Radioiodine treatment has 
been used to remove thyroid remnants in patients who 
have had total thyroidectomies for MTC (5); the reason-
ing is that any remaining C-cells in the patient wou ld be 
destroyed by radiation f rom adjacent fol l icular cells. In 
this patient, radioiodine treatment was not effective in 
destroying all C-cells. 
Other Kindreds 
Three additional families are understudy; one man wi th 
MTC whose mother had pheochromocytoma, and two 
because the proposit i have had C-cell hyperplasia on 
review of their thyroid gland histology. 
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